{"id":165856,"date":"2024-12-02T07:02:46","date_gmt":"2024-12-02T12:02:46","guid":{"rendered":"https:\/\/44.250.171.167\/?p=165856"},"modified":"2024-12-02T07:02:46","modified_gmt":"2024-12-02T12:02:46","slug":"asian-paints-ltd-q2fy25-44-fall-in-profits-3","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/asian-paints-ltd-q2fy25-44-fall-in-profits-3\/","title":{"rendered":"Asian Paints Ltd Q2FY25; 44% fall in Profits"},"content":{"rendered":"<p>AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products.<\/p>\n<p>Financial Results:<\/p>\n<p>Astrazeneca Pharma India Ltd reported Revenues for Q2FY25 of \u20b98,028.00 Crores down from \u20b98,479.00 Crore year on year, a fall of 5.32%.<\/p>\n<p>Total Expenses for Q2FY25 of \u20b97,093.00 Crores up from \u20b97,022.00 Crores year on year, a rise of 1.01%.<\/p>\n<p>Consolidated Net Profit of \u20b9694.00 Crores down 43.67% from \u20b91,232.00 Crores in the same quarter of the previous year.<\/p>\n<p>The Earnings per Share is \u20b97.24, down 42.40% from \u20b912.57 in the same quarter of the previous year.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-165857\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/HJ.png\" alt=\"\" width=\"1489\" height=\"1817\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/HJ.png 1489w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/HJ-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/HJ-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/HJ-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/HJ-1259x1536.png 1259w\" sizes=\"auto, (max-width: 1489px) 100vw, 1489px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products. Financial Results: Astrazeneca Pharma India Ltd reported Revenues for Q2FY25 of \u20b98,028.00 Crores down from \u20b98,479.00 Crore year on year, a fall of 5.32%. Total Expenses for Q2FY25 of \u20b97,093.00 Crores up from \u20b97,022.00 Crores year on year, [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":165857,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[10162],"class_list":["post-165856","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/HJ.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":166149,"url":"https:\/\/alphastreet.com\/india\/granules-india-ltd-q2fy25-5-fall-in-profits\/","url_meta":{"origin":165856,"position":0},"title":"Granules India Ltd Q2FY25; 5% fall in Profits","author":"Divyansh_Kasana","date":"December 24, 2024","format":false,"excerpt":"Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages. Financial Results: Granules India Ltd reported Revenues for Q2FY25 of \u20b9967.00 Crores down from \u20b91,189.00 Crore year on year, a fall of 18.67%. Total\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/GRANULES.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/GRANULES.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/GRANULES.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/GRANULES.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/GRANULES.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/GRANULES.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166311,"url":"https:\/\/alphastreet.com\/india\/aarti-drugs-ltd-q2fy25-12-fall-in-profits\/","url_meta":{"origin":165856,"position":1},"title":"Aarti Drugs Ltd Q2FY25; 12% fall in Profits","author":"Divyansh_Kasana","date":"January 10, 2025","format":false,"excerpt":"Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into manufacturing and selling Active Pharmaceutical Ingredients (API's), Pharma Intermediates, Specialty Chemicals as well as Formulations. Financial Results: Aarti Drugs Ltd reported Revenues for Q2FY25 of \u20b9598.00 Crores down\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/O-3.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/O-3.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/O-3.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/O-3.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/O-3.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/O-3.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":165443,"url":"https:\/\/alphastreet.com\/india\/ajanta-pharma-ltd-q2fy25-11-rise-in-profits\/","url_meta":{"origin":165856,"position":2},"title":"Ajanta Pharma Ltd Q2FY25; 11% rise in Profits","author":"Divyansh_Kasana","date":"November 7, 2024","format":false,"excerpt":"Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70). Financial Results: Ajanta Pharma Ltd reported Revenues for Q2FY25 of \u20b91,187.00 Crores up from \u20b91,028.00 Crore year on year, a rise of 15.47%. Total Expenses for Q2FY25 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":165787,"url":"https:\/\/alphastreet.com\/india\/natco-pharma-ltd-q2fy25-83-rise-in-profits\/","url_meta":{"origin":165856,"position":3},"title":"Natco Pharma Ltd Q2FY25; 83% rise in Profits","author":"Chirag Gupta","date":"November 21, 2024","format":false,"excerpt":"NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas. NATCO has established its presence in all three business segments viz. finished dosage formulations (\u201cFDF\u201d), active pharmaceutical ingredients (\u201cAPIs\u201d), Contract Manufacturing Business. Financial Results:\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-13-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-13-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-13-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-13-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-13-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-13-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":165862,"url":"https:\/\/alphastreet.com\/india\/aurobindo-pharma-ltd-q2fy25-9-rise-in-profits\/","url_meta":{"origin":165856,"position":4},"title":"Aurobindo Pharma Ltd Q2FY25; 9% rise in Profits","author":"Divyansh_Kasana","date":"December 2, 2024","format":false,"excerpt":"Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report Page No:159) Financial Results: Aurobindo Pharma Ltd reported Revenues for Q2FY25 of \u20b97,796.00 Crores up from \u20b97,219.00 Crore year on year, a rise of 7.99%. Total Expenses for\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/BK.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/BK.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/BK.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/BK.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/BK.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/BK.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":165734,"url":"https:\/\/alphastreet.com\/india\/abbott-india-ltd-q2fy25-43-fall-in-profits\/","url_meta":{"origin":165856,"position":5},"title":"Abbott India Ltd Q2FY25; 43% fall in Profits","author":"Divyansh_Kasana","date":"November 20, 2024","format":false,"excerpt":"Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India. It was established in 1944. Financial Results: Abbott India Ltd reported Revenues for Q2FY25 of \u20b91,628.00 Crores up from \u20b9497.00 Crore year on year, a rise of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/JR.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/JR.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/JR.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/JR.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/JR.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/JR.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/165856","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=165856"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/165856\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/165857"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=165856"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=165856"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=165856"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}